Impact of Global Geographic Region on Time in Therapeutic Range on Warfarin Anticoagulant Therapy: Data From the ROCKET AF Clinical Trial

BACKGROUND: Vitamin K antagonist (VKA) therapy remains the most common method of stroke prevention in patients with atrial fibrillation. Time in therapeutic range (TTR) is a widely cited measure of the quality of VKA therapy. We sought to identify factors associated with TTR in a large, internationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, Daniel E., Hellkamp, Anne S., Piccini, Jonathan P., Mahaffey, Kenneth W., Lokhnygina, Yuliya, Pan, Guohua, Halperin, Jonathan L., Becker, Richard C., Breithardt, Günter, Hankey, Graeme J., Hacke, Werner, Nessel, Christopher C., Patel, Manesh R., Califf, Robert M., Fox, Keith A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603243/
https://www.ncbi.nlm.nih.gov/pubmed/23525418
http://dx.doi.org/10.1161/JAHA.112.000067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603243/
https://www.ncbi.nlm.nih.gov/pubmed/23525418
http://dx.doi.org/10.1161/JAHA.112.000067

Ejemplares similares